Advantus Capital Management Inc lifted its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.1% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 98,302 shares of the healthcare conglomerate’s stock after acquiring an additional 1,026 shares during the period. Advantus Capital Management Inc owned 101.67% of UnitedHealth Group worth $19,252,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also modified their holdings of the company. Blue Chip Partners Inc. acquired a new stake in UnitedHealth Group in the second quarter worth approximately $110,000. Bruderman Asset Management LLC acquired a new stake in UnitedHealth Group in the second quarter worth approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its position in UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new stake in UnitedHealth Group in the second quarter worth approximately $121,000. Finally, Acrospire Investment Management LLC lifted its position in UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after purchasing an additional 400 shares during the period. Institutional investors and hedge funds own 86.01% of the company’s stock.
In other news, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the transaction, the insider now directly owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Over the last three months, insiders have sold 34,630 shares of company stock worth $7,669,416. Company insiders own 0.89% of the company’s stock.
Shares of UnitedHealth Group Inc (UNH) opened at $228.73 on Monday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. UnitedHealth Group Inc has a one year low of $156.09 and a one year high of $231.77. The stock has a market cap of $221,150.00, a price-to-earnings ratio of 25.99, a price-to-earnings-growth ratio of 1.57 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the previous year, the business earned $2.17 EPS. The company’s revenue was up 8.7% on a year-over-year basis. equities research analysts anticipate that UnitedHealth Group Inc will post 9.99 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st were paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.31%. The ex-dividend date was Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.09%.
UNH has been the subject of a number of recent research reports. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective for the company in a research report on Thursday, September 21st. Citigroup increased their price objective on UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a research report on Wednesday, October 18th. Leerink Swann reiterated a “buy” rating and set a $240.00 price objective (up previously from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Cantor Fitzgerald reiterated a “buy” rating and set a $208.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 17th. Finally, Jefferies Group increased their price objective on UnitedHealth Group from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Friday, October 13th. Three analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $226.74.
ILLEGAL ACTIVITY NOTICE: This piece was originally published by Equities Focus and is owned by of Equities Focus. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.equitiesfocus.com/2018/01/08/advantus-capital-management-inc-has-19-25-million-stake-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.